bioRxiv · 10.1101/542027
Abnormalities in Proinsulin Processing in Islets from Individuals with Longstanding T1D
Abstract
Work by our group and others has suggested that elevations in circulating proinsulin relative to C-peptide is associated with development of Type 1 diabetes (T1D). We recently described the persistence of detectable serum proinsulin in a large majority (95.9%) of individuals with longstanding T1D, including individuals with undetectable serum C-peptide. Here we describe analyses performed on human pancreatic sections from the nPOD collection (n=30) and isolated human islets (n=10) to further explore mechanistic etiologies of persistent proinsulin secretion in T1D. Compared to nondiabetic controls, immunostaining among a subset (4/9) of insulin positive T1D donor islets revealed increased numbers of cells with proinsulin-enriched, insulin-poor staining. Laser capture microdissection followed by mass spectrometry revealed reductions in the proinsulin processing enzymes prohormone convertase 1/3 (PC1/3) and carboxypeptidase E (CPE) in T1D donors. Twenty-four hour treatment of human islets with an inflammatory cytokine cocktail reduced mRNA expression of the processing enzymes PC1/3, PC2, and CPE. Taken together, these data provide new mechanistic insight into altered proinsulin processing in long-duration T1D and suggest that reduced {beta} cell prohormone processing is associated with proinflammatory cytokine-induced reductions in proinsulin processing enzyme expression.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Sims, E. K., Nyalwidhe, J., Syed, F., Bahnson, H. T., Haataja, L., Speake, C., Morris, M., Mirmira, R. G., Nadler, J., Mastracci, T. L., Arvan, P., Greenbaum, C. J., Evans-Molina, C.. 2019-02-08. Abnormalities in Proinsulin Processing in Islets from Individuals with Longstanding T1D. https://doi.org/10.1101/542027
Cite the original work for its findings. Save a collection to share your selection of sources.